4.8 Article

Splicing factor arginine/serine-rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome-based cellular communication

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Differential RNA splicing as a potentially important driver mechanism in multiple myeloma

Michael A. Bauer et al.

Summary: Disruption of normal RNA splicing patterns plays a major role in the pathogenesis of various diseases, particularly cancer. This study investigates the extent and impact of alternative splicing in multiple myeloma, identifying differentially spliced genes and showing potential implications for MM classification and patient risk stratification.

HAEMATOLOGICA (2021)

Review Oncology

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression

Almudena Garcia-Ortiz et al.

Summary: Multiple myeloma is a hematologic cancer characterized by clonal proliferation of plasma cells in the bone marrow, with disease progression influenced by the tumor microenvironment created by various cells and soluble factors. Understanding the elements that control the microenvironment could lead to better-targeted therapies for this incurable disease.

CANCERS (2021)

Article Cell Biology

Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma

Mengjie Guo et al.

Summary: The study showed that elevated RFWD2 expression in MM patients leads to adverse outcomes and drug resistance. RFWD2 is involved in controlling cell cycle, growth and death in MM biology. Targeting RFWD2 may be an effective strategy to inhibit cellular proliferation and overcome drug resistance in MM.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma

Chunyan Gu et al.

Summary: The study found that high expression of CHEK1 is associated with poor prognosis in multiple myeloma patients. CHEK1 promotes the development of multiple myeloma by inducing cell proliferation and drug resistance. CHEK1 also enhances the invasive potential and osteoclast differentiation of myeloma cells by activating chromosomal instability.

MOLECULAR CANCER (2021)

Review Biochemistry & Molecular Biology

Alternative splicing and cancer: a systematic review

Yuanjiao Zhang et al.

Summary: The study systematically describes the abnormal regulation and functions of alternative splicing in tumors, as well as introduces therapeutic strategies targeting splicing catalysis and regulatory proteins. Further research is needed to fully understand the association between alternative splicing and cancer.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Biochemistry & Molecular Biology

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability

Xiaozhu Tang et al.

Summary: The study revealed that BUB1B and circBUB1B_544aa play important roles in multiple myeloma (MM), being closely associated with poor outcomes and potentially serving as therapeutic targets for MM.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Cell Biology

Inhibiting extracellular vesicles formation and release: a review of EV inhibitors

Mariadelva Catalano et al.

JOURNAL OF EXTRACELLULAR VESICLES (2020)

Review Oncology

Roles and mechanisms of alternative splicing in cancer - implications for care

Sophie C. Bonnal et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Medicine, General & Internal

Emerging immunotherapies in multiple myeloma

Urvi A. Shah et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Review Biotechnology & Applied Microbiology

The current state and future directions of RNAi-based therapeutics

Ryan L. Setten et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Hematology

The emerging role of exosomes in multiple myeloma

Milad Moloudizargari et al.

BLOOD REVIEWS (2019)

Article Medicine, Research & Experimental

Tumor-derived extracellular vesicles inhibit osteogenesis and exacerbate myeloma bone disease

Liming Zhang et al.

THERANOSTICS (2019)

Review Cell Biology

Targeting splicing abnormalities in cancer

Anant A. Agrawal et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)

Review Oncology

Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential

Ingrid Spaan et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Review Pharmacology & Pharmacy

The application of CAR-T cell therapy in hematological malignancies: advantages and challenges

Zijun Zhao et al.

ACTA PHARMACEUTICA SINICA B (2018)

Article Cell Biology

Constitutive Activation of β-Catenin in Differentiated Osteoclasts Induces Bone Loss in Mice

Xin Sui et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Review Cell Biology

Modulating splicing with small molecular inhibitors of the spliceosome

Kerstin A. Effenberger et al.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)

Review Biochemistry & Molecular Biology

SR Proteins: Binders, Regulators, and Connectors of RNA

Sunjoo Jeong

MOLECULES AND CELLS (2017)

Article Medicine, General & Internal

Multiple myeloma

Shaji K. Kumar et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Biochemistry & Molecular Biology

CRISPR/Cas9 in Genome Editing and Beyond

Haifeng Wang et al.

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)

Review Biochemistry & Molecular Biology

CacyBP/SIP - Structure and variety of functions

Agnieszka M. Topolska-Wos et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)

Article Multidisciplinary Sciences

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Alexis C. Komor et al.

NATURE (2016)

Review Biochemistry & Molecular Biology

Splicing-factor alterations in cancers

Olga Anczukow et al.

Article Multidisciplinary Sciences

Calcyclin Binding Protein/Siah-1 Interacting Protein Is a Hsp90 Binding Chaperone

Agnieszka Goral et al.

PLOS ONE (2016)

Article Medicine, General & Internal

Multiple myeloma

Christoph Roellig et al.

LANCET (2015)

Review Immunology

Targeting the bone marrow microenvironment in multiple myeloma

Yawara Kawano et al.

IMMUNOLOGICAL REVIEWS (2015)

Review Biochemistry & Molecular Biology

Alternative splicing in cancer: implications for biology and therapy

J. Chen et al.

ONCOGENE (2015)

Review Cell Biology

The alternative splicing side of cancer

Giuseppe Biamonti et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)

Review Medical Laboratory Technology

Multiple myeloma: the bone marrow microenvironment and its relation to treatment

S. W. Andrews et al.

BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2013)

Article Cell Biology

Exosomes are natural carriers of exogenous siRNA to human cells in vitro

Tatyana A. Shtam et al.

CELL COMMUNICATION AND SIGNALING (2013)

Review Oncology

Wnt signaling in leukemias and myeloma: T-cell factors are in control

Machteld M. Tiemessen et al.

FUTURE ONCOLOGY (2013)

Article Medicine, Research & Experimental

BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression

Aldo M. Roccaro et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Biochemical Research Methods

Exosome-mediated delivery of siRNA in vitro and in vivo

Samir El-Andaloussi et al.

NATURE PROTOCOLS (2012)

Review Biotechnology & Applied Microbiology

The spliceosome as a target of novel antitumour drugs

Sophie Bonnal et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Review Biochemistry & Molecular Biology

Shuttling SR proteins: more than splicing factors

Laure Twyffels et al.

FEBS JOURNAL (2011)

Article Biochemistry & Molecular Biology

Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by β-Catenin

Wei Wei et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

Article Biotechnology & Applied Microbiology

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

Lydia Alvarez-Erviti et al.

NATURE BIOTECHNOLOGY (2011)

Article Biochemistry & Molecular Biology

Direct Ubiquitination of β-Catenin by Siah-1 and Regulation by the Exchange Factor TBL1

Yoana N. Dimitrova et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Pathogenesis of Myeloma Bone Disease

G. David Roodman

JOURNAL OF CELLULAR BIOCHEMISTRY (2010)

Review Biochemistry & Molecular Biology

Therapeutic Potential of Splice-Switching Oligonucleotides

John Bauman et al.

OLIGONUCLEOTIDES (2009)

Article Anatomy & Morphology

Rapid inactivation and apoptosis of osteoclasts in the maternal skeleton during the bone remodeling reversal at the end of lactation

Scott C. Miller et al.

ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2007)

Article Hematology

The molecular classification of multiple myeloma

Fenghuang Zhan et al.